Form 13-F position report

BIOGEN INC

Reported by Legal & General Group Plc

BIIB CUSIP 09062X103 Manager CIK 0000764068

Reported 1,514,802 shares, up 21,513 (1.4%) from the prior quarter.

Reported value 6.1%; share count 1.4% vs. the prior quarter.

Added
% of reported 13F value 0.07% This manager · Q3 2026
Shares 1,514,802 Quarter-end amount reported
Reported value $342,163,476 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 325833000
2022-03-31 303340000
2022-06-30 296931000
2022-09-30 381678000
2022-12-31 382330789
2023-03-31 377716821
2023-06-30 390107880
2023-09-30 344156767
2023-12-31 342895091
2024-03-31 281983668
2024-06-30 294444285
2024-09-30 242677847
2024-12-31 188092667
2025-03-31 175843087
2025-06-30 181705621
2025-09-30 223203335
2025-12-31 256874480
2026-03-31 247464698
2026-06-30 322640021
2026-09-30 342163476

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOGEN INC held by Legal & General Group Plc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,514,802 +21,513 (1.4%) 0.07% $342,163,476 2026-11-16
Q2 2026 Added 1,493,289 +143,457 (10.6%) 0.07% $322,640,021 2026-08-14
Q1 2026 Reduced 1,349,832 -109,765 (-7.5%) 0.06% $247,464,698 2026-05-08
Q4 2025 Reduced 1,459,597 -133,802 (-8.4%) 0.06% $256,874,480 2026-02-09
Q3 2025 Added 1,593,399 +146,583 (10.1%) 0.05% $223,203,335 2025-11-13
Q2 2025 Added 1,446,816 +161,789 (12.6%) 0.05% $181,705,621 2025-08-12
Q1 2025 Added 1,285,027 +55,020 (4.5%) 0.05% $175,843,087 2025-05-15
Q4 2024 Reduced 1,230,007 -21,946 (-1.8%) 0.05% $188,092,667 2025-02-13
Q3 2024 Reduced 1,251,953 -18,179 (-1.4%) 0.06% $242,677,847 2024-11-14
Q2 2024 Reduced 1,270,132 -37,588 (-2.9%) 0.08% $294,444,285 2024-08-14
Q1 2024 Reduced 1,307,720 -17,376 (-1.3%) 0.08% $281,983,668 2024-05-14
Q4 2023 Reduced 1,325,096 -13,982 (-1.0%) 0.11% $342,895,091 2024-02-15
Q3 2023 Reduced 1,339,078 -30,443 (-2.2%) 0.12% $344,156,767 2023-11-14
Q2 2023 Added 1,369,521 +10,974 (0.8%) 0.13% $390,107,880 2023-08-14
Q1 2023 Reduced 1,358,547 -22,112 (-1.6%) 0.14% $377,716,821 2023-05-15
Q4 2022 Reduced 1,380,659 -48,840 (-3.4%) 0.15% $382,330,789 2023-02-14
Q3 2022 Reduced 1,429,499 -26,471 (-1.8%) 0.15% $381,678,000 2022-11-14
Q2 2022 Added 1,455,970 +15,609 (1.1%) 0.11% $296,931,000 2022-08-22
Q1 2022 Added 1,440,361 +82,281 (6.1%) 0.09% $303,340,000 2022-05-16
Q4 2021 Reduced 1,358,080 -48,116 (-3.4%) 0.1% $325,833,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1121 managers reported BIOGEN INC for Q3 2026.

Managers reporting BIOGEN INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Reduced 16,780,911 -1,436,328 0.16% $3,790,472,025 54 qtrs
BlackRock Inc Added 16,089,189 +103,453 0.05% $3,634,226,091 9 qtrs
PRIMECAP MANAGEMENT CO CA Added 15,197,022 +42,416 2.13% $3,432,703,328 54 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 9,670,881 +19,764 0.05% $2,184,458,600 3 qtrs
STATE STREET CORPORATION Added 7,562,205 +217,878 0.05% $1,708,150,865 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 6,572,163 -32,773 0.07% $1,484,520,178 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 4,507,404 +58,109 0.05% $1,014,558,357 54 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 3,458,781 +341,312 0.14% $781,269,452 54 qtrs
MORGAN STANLEY Added 2,506,411 +95,140 0.03% $566,148,674 54 qtrs
JPMorgan Chase & Co Added 2,039,161 +216,021 0.03% $463,032,706 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,411,988
Shared
0
None
102,814

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.